Constellation Pharmaceuticals' Series B - III Round

Constellation Pharmaceuticals raised a round of funding on June 06, 2011.

Constellation Pharmaceuticals (NASDAQ: CNST) is a biopharmaceutical company dedicated to the development of therapeutics in the emerging field of Epigenetics, a new field of science involving selectiv…

Articles about Constellation Pharmaceuticals' Series B - III Round: